Concert Pharmaceuticals Announces Proposed Public Offering of Common Stock

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has commenced an underwritten public offering of its common stock. All of the shares in the offering are to be sold by Concert. Wells Fargo and JMP Securities are acting as joint book-running managers for the proposed offering. Concert intends to grant the underwriters... more →
Posted in: Press